Swiss Institute of Bioinformatics (SIB): A guided tour through neXtProt streamed

The event organized by the Swiss Institute of Bioinformatics (SIB) will be held on 22 September from 1 pm to 5 pm and it will be online. neXtProt is a platform developed at SIB that helps researchers answer questions relevant to human proteins. It provides a comprehensive set of high quality, fully traceable and standardized Read more about Swiss Institute of Bioinformatics (SIB): A guided tour through neXtProt streamed[…]

EMA and HMA: Launch of public consultation on joint network strategy to 2025

EMA and the Heads of Medicines Agencies (HMA) have developed a joint strategy for the next five years that is released for a two-month public consultation. The draft strategy details how the European medicines agencies’ network can continue to enable the supply of safe and effective medicines that meet patients’ needs in the face of challenges posed by Read more about EMA and HMA: Launch of public consultation on joint network strategy to 2025[…]

EATRIS: Translational Medicine Explained (TMex) digital course

Interested in discovering the landscape of Translational Medicine? Learn from scientists in academia, industry and regulatory agencies and join the 2020 TMex winter school!  EATRIS has organized the TMex (Translational Medicine Explained) Winter School that is targeted to PhD students in the second half of their PhD, early postdocs and other young scientists who are involved in Read more about EATRIS: Translational Medicine Explained (TMex) digital course[…]

ELIXIR: 3rd Biohackathon Europe is going virtually

Following the success of the past Biohackathons (2018, 2019), and building on the Biohackathons organised by National Bioscience Database Center (NBDC) and Database Center for Life Science (DBCLS), ELIXIR is running Biohackathon Europe 2020 virtually this year. The hope is to build on the previous success and encourage more ELIXIR and non-ELIXIR participants to take Read more about ELIXIR: 3rd Biohackathon Europe is going virtually[…]

INB/ELIXIR-ES & BSC: 19th European Conference on Computational Biology

The Spanish National Bioinformatics Institute (INB/ELIXIR-ES) and the Barcelona Supercomputing Center (BSC) organize 19th European Conference on Computational Biology (ECCB2020), this year the motto is Planetary Health and Biodiversity. The ECCB2020 is the main computational biology and bioinformatics conference this year in Europe and will take place from August 31st until September 8th, 2020. Due to the Read more about INB/ELIXIR-ES & BSC: 19th European Conference on Computational Biology[…]

Share4Rare: The burden of COVID-19 in people affected by a rare disease

People with rare diseases are doubly vulnerable to COVID-19: on the one hand, many of these pathologies put patients’ health at a higher risk during a SARS-CoV-2 infection, and, on the other hand, confinement and the lack of medical care due to the saturation of certain health services are making it difficult to treat these patients. Read more about Share4Rare: The burden of COVID-19 in people affected by a rare disease[…]

BBMRI-ERIC & ESBB: EUROPE BIOBANK WEEK 2020 WILL BE AN ONLINE EVENT!

17 – 20 November 2020 Organisers BBMRI-ERIC and ESBB have decided that the Europe Biobank Week 2020, originally scheduled to take place from October 12-15, 2020 in Sofia, Bulgaria will be replaced in its physical form by a virtual online event. #EBW20 virtual conference will take place a few weeks later, on 17-20 November. More Read more about BBMRI-ERIC & ESBB: EUROPE BIOBANK WEEK 2020 WILL BE AN ONLINE EVENT![…]

ELIXIR Toxicology Community Workshop

The ELIXIR Heads of Nodes have approved a proposal by a nascent Toxicology Community to become part of ELIXIR’s portfolio of Communities. The ELIXIR Heads of Nodes have approved a proposal by a nascent Toxicology Community to become part of ELIXIR’s portfolio of Communities, subject to the preparation of a Community white paper. This workshop Read more about ELIXIR Toxicology Community Workshop[…]

IMI2 JU Scientific Committee recommendations regarding rare diseases

In the Innovative Medicine Initiative (IMI2) report regarding rare diseases recently published. In the report, beside the several relevant recommendations on different topics such as digital solutions, innovative technologies, and a more explicit value framework for orphan drugs, a list of common challenges, and a note about public private partnership. In addition, EJP RD as Read more about IMI2 JU Scientific Committee recommendations regarding rare diseases[…]

European Research and Innovation Days

The European Research and Innovation Days will take place on 22, 23, and 24 September 2020. Research and innovation will be key to ensure a transition to a sustainable, inclusive, and resilient post-corona society. This year’s format will provide an opportunity to connect, take stock of research and innovation achievements in the global response to Read more about European Research and Innovation Days[…]